HealthLynked Corp.
OTC:HLYK
0.0375 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3.008 | 5.722 | 5.858 | 9.198 | 6.133 | 4.019 | 2.259 | 2.104 | 1.946 | 2.549 | 2.061 |
| Cost of Revenue
| 0.096 | 3.374 | 0.463 | 3.02 | 1.164 | 4.239 | 2.367 | 2.022 | 1.56 | 1.459 | 1.353 |
| Gross Profit
| 2.912 | 2.349 | 5.395 | 6.178 | 4.969 | -0.22 | -0.108 | 0.081 | 0.386 | 1.09 | 0.708 |
| Gross Profit Ratio
| 0.968 | 0.41 | 0.921 | 0.672 | 0.81 | -0.055 | -0.048 | 0.039 | 0.198 | 0.428 | 0.344 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 5.034 | 6.855 | 7.913 | 8.045 | 5.645 | 5.309 | 5.207 | 3.871 | 3.104 | 1.144 | 0.702 |
| Selling & Marketing Expenses
| -1.995 | -3.231 | -3.336 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.344 |
| SG&A
| 3.039 | 3.623 | 7.913 | 8.045 | 5.645 | 5.309 | 5.207 | 3.871 | 3.104 | 1.144 | 1.046 |
| Other Expenses
| 4.551 | 2.877 | 3.396 | 3.177 | 2.396 | 1.918 | 0.024 | 0.024 | 0.016 | 0 | 0 |
| Operating Expenses
| 7.59 | 6.5 | 11.309 | 11.222 | 8.041 | 7.228 | 5.231 | 3.895 | 3.12 | 1.165 | 0.727 |
| Operating Income
| -4.678 | -4.152 | -5.914 | -5.043 | -3.072 | 3.945 | -2.972 | -1.791 | -1.174 | -0.075 | -0.387 |
| Operating Income Ratio
| -1.555 | -0.726 | -1.009 | -0.548 | -0.501 | 0.982 | -1.316 | -0.852 | -0.604 | -0.029 | -0.188 |
| Total Other Income Expenses Net
| -1.454 | 0.538 | 0.592 | -5.369 | -2.683 | -2.32 | -2.819 | -0.79 | -0.202 | -0.014 | 0.302 |
| Income Before Tax
| -6.131 | -3.614 | -8.067 | -10.413 | -5.755 | -5.529 | -5.791 | -2.581 | -1.376 | -0.089 | -0.085 |
| Income Before Tax Ratio
| -2.038 | -0.632 | -1.377 | -1.132 | -0.938 | -1.376 | -2.563 | -1.227 | -0.707 | -0.035 | -0.041 |
| Income Tax Expense
| 0 | 0 | 0.748 | -0 | 0.399 | 8.795 | 0.499 | 0.1 | 0.037 | 0 | 0 |
| Net Income
| -6.131 | -1.012 | -8.816 | -10.412 | -6.154 | -14.323 | -5.791 | -2.581 | -1.376 | -0.089 | -0.085 |
| Net Income Ratio
| -2.038 | -0.177 | -1.505 | -1.132 | -1.003 | -3.564 | -2.563 | -1.227 | -0.707 | -0.035 | -0.041 |
| EPS
| -0.022 | -0.004 | -0.036 | -0.046 | -0.043 | -0.14 | -0.074 | -0.037 | -0.021 | -0.002 | -0.002 |
| EPS Diluted
| -0.022 | -0.004 | -0.036 | -0.046 | -0.043 | -0.14 | -0.074 | -0.037 | -0.021 | -0.002 | -0.002 |
| EBITDA
| -4.364 | -2.75 | -7.05 | -9.853 | -4.727 | -3.815 | -3.588 | -2.054 | -1.323 | -0.054 | -0.338 |
| EBITDA Ratio
| -1.451 | -0.481 | -1.203 | -1.071 | -0.771 | -0.949 | -1.588 | -0.977 | -0.68 | -0.021 | -0.164 |